Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties
AssigneeAlliance of Cardiovascular Researchers
InventorsAntonio MARCHINI, Tiina MARTTILA, Amit KULKARNI, Eckhard U. ALT
Life of this patent
Estimating the term…
Abstract
Novel engineered oncolytic protoparvoviruses are described to be used in cancer therapy. The engineered protoparvoviruses contain at least one deletion in the untranslated region and a silencer sequence that remains stably integrated into the viral genome during extensive virus propagation. The novel viruses can be used for the silencing of relevant cancer-related genes, providing to the virus a new anticancer mechanism of action.
Claims32
An engineered parvovirus, the parvovirus having a left palindromic terminal sequence, a coding sequence, a non-coding region, and a right palindromic terminal sequence, wherein:
- a) the coding sequence comprising a first sequence encoding non-structural proteins and a second sequence encoding structural capsid proteins;
- and
- b) a first deletion is located between the first sequence and the second sequence and a second deletion is located within the untranslated region;
An engineered LuIII parvovirus having a left palindromic terminal sequence, a coding sequence, a non-coding region, and a right palindromic terminal sequence, wherein a deletion is located within the non-coding region.
The method of 29, wherein the second oncolytic virus is an engineered H-1PV parvovirus, the parvovirus having a left palindromic terminal sequence, a coding sequence, a non-coding region, and a right palindromic terminal sequence, wherein:
- the coding sequence comprising a first sequence encoding non-structural proteins and a second sequence encoding structural capsid proteins;
- and a first deletion is located between the first sequence and the second sequence and a second deletion is located within the untranslated region, wherein the engineered H-1PV parvovirus further comprising a silencer expressing sequence inserted in the non-coding region.
Dependencies are inferred from the claim text.